Charles Abrams

Title: Innovations of Charles Abrams in African Swine Fever Vaccine Development

Introduction

Charles Abrams is a notable inventor based in Woking, GB. He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for African Swine Fever (ASF). With a total of 2 patents, Abrams has focused on creating effective solutions to combat this devastating disease in swine populations.

Latest Patents

Abrams' latest patents include an attenuated African Swine Fever virus vaccine. This invention provides an attenuated ASF virus that lacks functional versions of specific genes, including the DP148R gene. The vaccine aims to prevent ASF and also explores the potential for intranasal administration of the attenuated virus. Another patent focuses on an attenuated ASF virus that lacks functional versions of multigene-family 360 genes (9L, 10L, 11L, 12L, 13L, and 14L) and multigene-family 505 genes (1R, 2R, 3R, and 4R), further contributing to the development of effective vaccines against ASF.

Career Highlights

Charles Abrams is affiliated with The Pirbright Institute, where he conducts his research and development work. His innovative approach to vaccine development has positioned him as a key figure in the fight against ASF, which poses a significant threat to global swine populations.

Collaborations

Abrams collaborates with esteemed colleagues, including Ana-Luisa Reis and Chris Netherton. Their combined expertise enhances the research efforts at The Pirbright Institute, fostering advancements in veterinary virology.

Conclusion

Charles Abrams is a pioneering inventor whose work on African Swine Fever vaccines is crucial for the agricultural sector. His contributions through innovative patents and collaborations are vital in addressing the challenges posed by this disease.